Nov 27, 2014 at 14:56 | Source: Moneycontrol.com
SMS Pharmaceuticals Ltd has informed BSE that the legal disputes between the Company and M/s.Natco Pharma Limited have been amicably settled. Out of the settlement, the Company has received a sum of Rs.15.07 crores from M/s.Natco Pharma Limited apart from the balance principal amount receivable from the respective courts.
Nov 25, 2014 at 11:56 | Source: Moneycontrol.com
Gufic Biosciences Ltd has informed BSE that the Board of Directors of the Company has, by resolution passed at the meeting held on November 13, 2014, re-constituted the Committees of the Company.
Nov 24, 2014 at 15:24 | Source: Moneycontrol.com
AstraZeneca Pharma India Ltd has informed BSE that Mr. Robert Haxton has resigned as the Wholetime Director of the Company. The Board has accepted the resignation of Mr. Haxton and that he would be relieved from the said position, effective December 14, 2014.
Nov 24, 2014 at 14:15 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Nov 20, 2014 at 13:47 | Source: CNBC-TV18
HB Joshipura, Managing Director of Glaxosmithkline, said parent company GSK Plc has no plans to delist it from Indian bourses.
Nov 19, 2014 at 14:39 | Source: Moneycontrol.com
Bafna Pharmaceuticals Ltd has informed BSE that CRISIL has upgraded the rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for Short term Rating in respect of Total bank facilities.
Nov 17, 2014 at 20:49 | Source: CNBC-TV18
NSE FinWiz at GlaxoSmithKline (GSK) Pharmaceuticals, Mumbai to gauge financial planning thoughts and notions of the young employees on investments and financial planning.
Nov 14, 2014 at 19:17 | Source: CNBC-TV18
Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting sources.
Nov 14, 2014 at 15:52 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the Board of Directors of the Company at is meeting held on November 14, 2014, has declared Interim dividend at Rs 5 (50 percent) per share for the financial year 2014- 2015.
Nov 14, 2014 at 11:05 | Source: Moneycontrol.com
Albert David Ltd has informed BSE that Mr. D. D. Binani has resigned from the Board of the Directors of the Company which has been accepted by the Board in their meeting held on November 13, 2014.